Latest News

Functional Improvement of non-infarcT relaTed coronary artery stenosis by Extensive LDL-C Reduction with a PCSK9 Antibody (FITTER)

Key Points: Adverse cardiovascular events can still occur from atherosclerotic events in…

A Low-Dose Triple Single-Pill Combination Effective at Lowering Blood Pressure

Key Points: A single pill containing low doses of three different medicines…

OCCUPI: Optical Coherence Tomography (OCT) Outperforms Conventional Angiography in Guiding Revascularization for Complex Coronary Lesions

Key Points: In all-comer populations, coronary imaging guidance shows superior outcomes compared…

GUARD–AF: Wearable ECG Patch Increased the Yield of AF Diagnosis

Key Points: A 14-day heart rhythm monitoring with a wearable patch in…

OCEANIC AF – Asundexian is inferior to apixaban for stroke prevention in patients with atrial fibrillation

Key Points: Factor XIa inhibition may reduce stroke risk while causing bleeding.…

IVORY FINALE: Low-Dose IL-2 Reduces Arterial Inflammation after ACS

Key Points: While inflammation is critical to the pathogenesis of atherosclerosis, few…

A Single Combined Measure Of hsCRP, LDL-C, And Lp(A) Predicts Incident CV Events Over 30 Years Among Women’s Health Study Participants

Key Points: While drug trials evaluate the short-term cardiovascular risk associated with…

ASSURE DES: No Difference In Ischemic Events If Aspirin Is Interrupted Or Continued In Patients With DES Undergoing Non-Cardiac Surgery

Key Points: Anti-platelet therapy after coronary drug eluting stent (DES) placement reduces…

NOTION-3: Revascularization in Patients Undergoing TAVI Associated with Lower Risk of MACE vs Conservative Treatment

Key Points: The NOTION-3 trial found that FFR-guided revascularization with PCI in…

TAVI Superior to Surgical Aortic Valve Replacement in Women: RHEIA Trial

Key Points: The RHEIA trial found that TAVI was superior to surgical…

SWEDEGRAFT Trial: No Advantage of No-Touch vs Conventional Vein Harvesting in Coronary Artery Bypass Surgery

Key Points: The SWEDEGRAFT study is a prospective, binational multicenter, open-label, registry-based…

Transcatheter Mitral-valve Repair Lowers Hospitalization or CV Death vs Medical Therapy Alone in HF with Moderate to Severe MR: RESHAPE-HF2 Trial

Key Points: The Mitral Transcatheter Edge-to-Edge Repair (M-TEER) procedure with the MitraClip…

Continuation of Anticoagulation Non-Inferior to Interruption during TAVI: POPular PAUSE TAVI Trial.

Key Points: Many patients who undergo transcatheter aortic-valve implantation (TAVI) have an…

Pooled Analysis Showed Semaglutide Reduced Combined CV death or Worsening HF and Worsening HF alone but No Significant Effect on CV Death

Key Points: Heart failure with mildly reduced or preserved ejection fraction (hereafter…

Transcatheter Edge-To-Edge Repair Is Non-Inferior To Surgery In Patients With Secondary Mitral Regurgitation: MATTERHORN Trial

Key Points: The MATTERHORN trial found that the transcatheter edge-to-edge repair (TEER)…